Guido Dalbagni. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Adjuvants, Immunologic/therapeutic useAdministration, IntravesicalAntibiotics, Antineoplastic/administration & dosageBCG Vaccine/therapeutic useHumansMitomycin/administration & dosageRisk FactorsTreatment OutcomeUrinary Bladder Neoplasms/drug therapy
Substances: See more » Adjuvants, ImmunologicAntibiotics, AntineoplasticBCG VaccineMitomycin
Year: 2009 PMID: 19427109 DOI: 10.1016/j.eururo.2009.04.041
Source DB: PubMed Journal: Eur Urol ISSN: 0302-2838 Impact factor: 20.096